Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.
The #ALS space—and the HEALEY ALS Platform Trial—saw two more failures this week, from Denali Therapeutics and AbbVie/Calico Life Sciences. After a disappointing 2024 for the space ...
Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained 26.6% against the industry’s decline of 14.3%. The stock has also ...
Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained ...
The multi-centre, placebo-controlled, double-blind trial will assess the therapy’s safety, pharmacodynamics, efficacy, and pharmacokinetics in adult ALS patients. Sean M Healey & AMG Centre for ...
The multi-centre, placebo-controlled, double-blind trial will assess the therapy’s safety, pharmacodynamics, efficacy, and pharmacokinetics in adult ALS patients. Sean M Healey & AMG Centre for ALS ...
Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...
Gov. Maura Healey filed a $2.5 billion borrowing bill Tuesday that would dump cash into Massachusetts’ public higher education system to update aging infrastructure that the first-term Democrat ...
Governor Maura Healey spent on average one in every three days outside of Massachusetts in the months leading up to Election Day, a stretch in which she raised money in California, repeatedly ...
(WJAR) — The Maura Healey administration announced a bill on Tuesday that aims to modernize public higher education in Massachusetts. She made the announcement in Bridgewater at the campus of ...